PortViewPortView
Pasithea Therapeutics Corp. logo

Pasithea Therapeutics Corp. (KTTA) Stock Analysis

NASDAQHealthcareBiotechnology

$0.56-0.39%
1-year price historyRange $0.29 – $1.47
52-week range$0.56
$0.28$2.06

What Pasithea Therapeutics Corp. does

Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.

Key metrics

Market cap
$18.74M
P/E (TTM)
-0.35
EPS (TTM)
$-1.60
Beta
0.29
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$0.50
200-day avg
$0.74
52-week high
$2.06
52-week low
$0.28
CEO
Tiago Reis Marques

ETFs linked to KTTA

Broad-market and Healthcare sector ETFs an investor holding Pasithea Therapeutics Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how KTTA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KTTA in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Pasithea Therapeutics Corp.?
Pasithea Therapeutics Corp. trades under the ticker KTTA on NASDAQ.
Which exchange is KTTA listed on?
KTTA is listed on NASDAQ.
What sector does Pasithea Therapeutics Corp. operate in?
Pasithea Therapeutics Corp. is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KTTA in a portfolio?
PortView shows KTTA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.